BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31802833)

  • 1. Cystic duct cancer: Should it be deemed as a type of gallbladder cancer?
    Yu TN; Mao YY; Wei FQ; Liu H
    World J Gastroenterol; 2019 Nov; 25(44):6541-6550. PubMed ID: 31802833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and prognosis of advanced biliary carcinoma centered in the cystic duct.
    Nakanishi Y; Tsuchikawa T; Okamura K; Nakamura T; Noji T; Asano T; Tanaka K; Shichinohe T; Mitsuhashi T; Hirano S
    HPB (Oxford); 2018 Jan; 20(1):28-33. PubMed ID: 28890312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
    Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
    [TBL] [Abstract][Full Text] [Related]  

  • 4.  Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.
    Waseem D; Tushar P
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):133-139. PubMed ID: 28051802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for a new classification for perihilar cholangiocarcinoma based on tumour depth.
    Shinohara K; Ebata T; Shimoyama Y; Nakaguro M; Mizuno T; Matsuo K; Nagino M
    Br J Surg; 2019 Mar; 106(4):427-435. PubMed ID: 30675908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perihilar cholangiocarcinoma Bismuth type IV: Resection frequently possible].
    Strobel O; Büchler MW
    Chirurg; 2017 Aug; 88(8):707. PubMed ID: 28717821
    [No Abstract]   [Full Text] [Related]  

  • 7. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
    Khan SA; Emadossadaty S; Ladep NG; Thomas HC; Elliott P; Taylor-Robinson SD; Toledano MB
    J Hepatol; 2012 Apr; 56(4):848-54. PubMed ID: 22173164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma.
    Haga Y; Miyamoto A; Wada Y; Takami Y; Takeuchi H
    HPB (Oxford); 2016 Mar; 18(3):271-8. PubMed ID: 27017167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumors of the gallbladder and bile ducts.
    Baillie J
    J Clin Gastroenterol; 1999 Jul; 29(1):14-21. PubMed ID: 10405225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
    Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
    Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
    Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gallbladder and bile duct carcinoma].
    Kubicka S; Manns MP
    Internist (Berl); 2000 Sep; 41(9):841-7. PubMed ID: 11006871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gallbladder and bile duct carcinoma. Biology and pathology].
    Tannapfel A; Wittekind C
    Internist (Berl); 2004 Jan; 45(1):33-41. PubMed ID: 14735242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
    Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mössner J; Caca K
    Z Gastroenterol; 2005 Mar; 43(3):305-15. PubMed ID: 15765304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carcinoma of the biliary tract].
    Miyazaki I; Konishi I; Nagakawa T
    Gan No Rinsho; 1986 Aug; 32(10):1365-8. PubMed ID: 3783969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma.
    Nakata T; Kobayashi A; Miwa S; Soeda J; Miyagawa S
    World J Surg; 2007 Jan; 31(1):155-61; discussion 162-3. PubMed ID: 17180477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer.
    Wang J; Bo X; Suo T; Liu H; Ni X; Shen S; Li M; Xu J; Liu H; Wang Y
    Cancer Sci; 2018 Jul; 109(7):2266-2274. PubMed ID: 29723922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological features of primary carcinoma of the cystic duct.
    Nakata T; Kobayashi A; Miwa S; Soeda J; Uehara T; Miyagawa S
    J Hepatobiliary Pancreat Surg; 2009; 16(1):75-82. PubMed ID: 19096752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.